Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy

Table 1

Patient data such as gender, treated eye, age, age of diagnosis, and duration of the disease.

Patients	Gender	Treated eye	Age	Age of diagnosis	Duration of the disease
#1	F	LE	48	30	18
#2	F	RE	23	13	10
#3	F	RE	27	17	10
#4	F	LE	26	21	5
#5	F	RE	33	25	8
#6	M	LE	40	25	15
#7	M	LE	45	25	20
#8	M	LE	33	22	11
#9	M	RE	28	22	6
#10	F	RE	27	17	10